PP

Prajula Parayil

Active Director Designated Partner DIN 10853320
DIN 10853320 First appointment Nov 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Prajula Parayil

Data last updated:

Prajula Parayil is a Designated Partner at Aidin Pharma Llp (since 2024).

DIN 10853320
Primary Designation Designated Partner
First Appointment 26 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aidin Pharma Llp ACK-5470
Designated Partner26 Nov 20242024Active

Board colleagues of Prajula Parayil

NameDINCompanyDesignation
Fathima Bevi Aboobacker10853318Aidin Pharma LlpDesignated Partner
Irfana Issath10853319Aidin Pharma LlpDesignated Partner
Jesrin10853317Aidin Pharma LlpDesignated Partner
Remith Thondiyil10853316Aidin Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Aidin Pharma Llp
Premium access

Shareholding and investment profile for Prajula Parayil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prajula Parayil

Prajula Parayil currently holds 1 directorship: Aidin Pharma Llp (Designated Partner, since 26 Nov 2024).

Prajula Parayil was first appointed on 26 Nov 2024 as Designated Partner at Aidin Pharma Llp.

The current boards of Prajula Parayil's companies include Fathima Bevi Aboobacker (Aidin Pharma Llp), Irfana Issath (Aidin Pharma Llp), Jesrin (Aidin Pharma Llp), Remith Thondiyil (Aidin Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available